GERON CORP GERON ORD SHS (0IV3.L) Financials

0IV3.L Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 413.0 million 122.4 million
2023-06-30 415.3 million 116.9 million
2023-03-31 424.9 million 98.8 million
2022-12-31 190.6 million 110.6 million

0IV3.L Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -51.0 million 7.2 million
2023-06-30 -29.8 million 3.9 million
2023-03-31 -46.7 million 3.1 million
2022-12-31 -34.7 million 2.3 million

0IV3.L Net Income

No data available :(

0IV3.L Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 314.1 million - -
2023-06-30 371.9 million - -
2023-03-31 381.1 million - -
2022-12-31 173.1 million - -

0IV3.L Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 579.5 million
2023-06-30 547.3 million
2023-03-31 544.5 million
2022-12-31 408.1 million

0IV3.L Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 192000 29.4 million - -
2023-06-30 202000 35.5 million - -
2023-03-31 372000 27.2 million - -
2022-12-31 140000 28.2 million - -

0IV3.L Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 164000 -
2023-06-30 29000 275000
2023-03-31 21000 251000
2022-12-31 103000 229000

0IV3.L

Price: $3.80

52 week price:
1.73
4.22

Earnings Per Share: -0.36 USD

P/E Ratio: -6.47

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Market Capitalization: 5.7 million

Links: